plavix 中文意思是什麼

plavix 解釋
保栓通
  1. Results of the ticlid or plavix post - stents （ topps ） trial : do they justify the switch from ticlopidine to clopidogrel after coronary stent placement

    支架植入后抵克立得或氯吡格雷治療療效比較試驗（ topps ）結果：它們足以構成冠脈支架植入后從抵克立得轉為氯吡格雷治療的理由嗎？
  2. International circulation ： how long is the time that the the patients should take plavix （ clopidogrel ） after intervention operation

    問：您認為在介入手術后服用波力維（氯吡格雷）多長時間比較合適？
  3. Plavix in high risk unstable angina : a report of 56 cases

    氯吡格雷治療高危不穩定型心絞痛56例
  4. Instead of prescribing acid suppressing drugs to patients who cannot tolerate aspirin, the american college of cardiology and the american heart association strongly recommend substitution of aspirin with another drug called clopidogrel ( plavix ). plavix is an anti - platelet drug that effectively prevents clogging of blood vessels

    但美國心臟病專科學院及美國心臟病學會則大力建議，對不宜服用亞士匹靈的病人，可使用氯比格雷（ clopidogrel ，商品名plavix ） ，來代替亞士匹靈。
  5. In other words, the risk of recurrent ulcer bleeding was more than 10 times higher in the group receiving plavix than the group receiving aspirin plus a proton - pump inhibitor

    由此推斷，病人服用plavix而有潰瘍出血復發的機會，較服用亞士匹靈加上胃酸抑制劑的一組增逾十倍。
  6. A total of 320 patients who had coronary heart disease or stroke were randomly assigned to receive plavix or aspirin plus a proton - pump inhibitor for one year

    研究對象為320位曾有潰瘍出血的冠心病或中風的病人，一組病人獲處方plavix藥物，另一組則獲處方亞士匹靈加上胃酸抑制劑，為期一年。
  7. Unlike aspirin, plavix was thought to induce no harm to the stomach. according to the hospital authority, the annual expenditure on plavix is on a rising trend and exceeded $ 16 million hkd last year

    根據本港醫管局的資料顯示，本港每年用在plavix藥物上的開支正不斷增加，以去年為例， plavix藥物的開支便達到一千六百萬港元。
  8. Professor chan concluded that contrary to the current u. s. guidelines, plavix is contraindicated in patients who cannot tolerate aspirin. these high - risk patients should receive a combination of aspirin and a proton - pump inhibitor

    陳教授總結：今次研究結果與美國現行使用醫療指引恰恰相反，對于曾患有潰瘍出血的冠心病或中風的病人，處方plavix藥物，其實並不合宜；他們應獲處方亞士匹靈加上胃酸抑制劑。
  9. The gi research team of the department of medicine and therapeutics at the chinese university of hong kong led by professor francis chan ka - leung performed the first double - blind randomized trial to compare plavix with the combination of aspirin and a proton - pump inhibitor for patients who had previous ulcer bleeding

    由香港中文大學內科及藥物治療學系教授陳家亮教授率領的腸胃科研究小組，完成了首個雙盲隨機測試的研究，比較曾患潰瘍病人服用plavix及服用亞士匹靈加上胃酸抑制劑兩者的療效。
分享友人
分享到 Line

分享到臉書